Navigation System Provides Accurate Guidance

The system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

The system has been cleared by the U.S. Food and Drug Administration (FDA) for coronary vasculature procedures, neurovascular, and peripheral applications in conjunction with the Cronus magnetically enabled .014-inch vascular guidewires.
Both Niobe and Cronus are products of Stereotaxis (St. Louis, MO, USA).

"While we have no current plans to immediately move into peripheral and neurovascular clinical applications, this clearance provides us with the flexibility to do so at a time of our choosing,” said Bevil Hogg, president and CEO of Stereotaxis. "We believe this latest clearance is further evidence of the broad applicability of our system to the entire body.”



Related Links:
Stereotaxis